Completed NA INTERVENTIONAL 2-arm NCT02698007

Safety and Benefits of Using Laryngeal Mask Airway to Keep Airway Potency During Fiber-optic Bronchoscopy

Sponsor: Rabin Medical Center

Conditions Chronic Obstructive Pulmonary Disease Respiratory Disease Undergoing Elective Bronchoscopy.

Interventions Laryngeal Mask Airway (LMA)

Updated 6 times since 2017 Last updated: Oct 13, 2016 Started: Apr 30, 2016 Primary completion: Oct 31, 2016 Completion: Oct 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02698007, this NA trial focuses on Chronic Obstructive Pulmonary Disease and Respiratory Disease Undergoing Elective Bronchoscopy. and remains completed. Sponsored by Rabin Medical Center, it has been updated 6 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Apr 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rabin Medical Center

Data source: Rabin Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Petah Tikva, Israel